Literature DB >> 24108346

[Mortality trends and years of potential life lost from prostate cancer in the 32 states and 7 sociecononomic regions of Mexico, 2000-2010].

Juan Jesús Sánchez-Barriga1.   

Abstract

OBJECTIVE: To determine trends of mortality from prostate cancer (PC) and years of potential life lost (YPLL) by federative entity and by socioeconomic region in the period 2000-2010.
METHODS: Records of mortality associated with PC 2000-2010 were obtained from the National Information System of the Secretariat of Health. This information is generated by the National Institute of Statistics and Geography through death certificates issued throughout the country. International Classification of Diseases, 10th revision, codes corresponding to the basic cause of death from PC were identified. Rates of mortality nationwide, by state, and by socioeconomic region were calculated. Rates of YPLL were calculated by federative entity and by socioeconomic region. The seven socioeconomic regions were elaborated by the National Institute of Statistics and Geography and include the 31 states and Mexico City according to indicators that are related to well-being such as education, occupation, health, housing, and employment.
RESULTS: Raw mortality rates per 100,000 inhabitants who died from PC increased from 7.8 to 9.8 between 2000-2010. The states and socioeconomic regions with the higher rates of mortality from PC were Sinaloa, Sonora, Baja California Sur, Nayarit, Colima and regions 6 and 3. The state and socioeconomic regions with higher rate of APVP from PC were Aguascalientes, Nuevo León, Campeche, Baja California Sur, Durango and regions 6, 5, 3, 1 and 2.
CONCLUSIONS: Raw mortality rates per 100,000 inhabitants who died from PC increased from 7.8 to 9.8 between 2000-2010. The states and socioeconomic region with the higher mortality rates were Sinaloa, Sonora, Baja California Sur, Nayarit, Colima and regions 6 and 3. Mexico.

Entities:  

Mesh:

Year:  2013        PMID: 24108346

Source DB:  PubMed          Journal:  Gac Med Mex        ISSN: 0016-3813            Impact factor:   0.302


  3 in total

1.  Radium-223 IN metastatic hormone-sensitive high-grade prostate cancer: initial experience.

Authors:  García-Pérez Francisco Osvaldo; Medina-Ornelas Sevastián Salvador; Santana-Ríos Zael; Sobrevilla-Moreno Nora
Journal:  Am J Nucl Med Mol Imaging       Date:  2017-11-01

2.  Medical Expenditure for Chronic Diseases in Mexico: The Case of Selected Diagnoses Treated by the Largest Care Providers.

Authors:  Alejandro Figueroa-Lara; Miguel Angel Gonzalez-Block; Jose Alarcon-Irigoyen
Journal:  PLoS One       Date:  2016-01-08       Impact factor: 3.240

3.  Disability-Adjusted Life Years for Cancer in 2010⁻2014: A Regional Approach in Mexico.

Authors:  Efrén Murillo-Zamora; Oliver Mendoza-Cano; Mónica Ríos-Silva; Ramón Alberto Sánchez-Piña; Martha Alicia Higareda-Almaraz; Enrique Higareda-Almaraz; Agustin Lugo-Radillo
Journal:  Int J Environ Res Public Health       Date:  2018-04-26       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.